Andreas Rieckmann, PhD

Specialist Value Evidence Analytics
H.Lundbeck A/S, Copenhagen, Denmark;, Denmark

Poster(s):

• (73) Persistence with Eptinezumab and Other Preventive Treatments for Chronic Migraine in the United States: Results of a Retrospective, Observational, Cohort Study
  Wednesday, October 29, 2025